Cargando…

Syndrome of hereditary tyrosinemia in mink

Detalles Bibliográficos
Autores principales:	Christensen, K, Venge, O, Sørensen, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1978
Materias:	Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316394/ http://dx.doi.org/10.1186/1297-9686-10-4-589C

Ejemplares similares

Revisiting hereditary tyrosinemia Type 1—spectrum of radiological findings
por: Shaikh, Sana, et al.
Publicado: (2018)

Hereditary Tyrosinemia Type 1 in Jordan: A Retrospective Study
por: Megdadi, Noor A., et al.
Publicado: (2021)

Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts
Publicado: (1985)

Protein Degradation and the Pathologic Basis of Phenylketonuria and Hereditary Tyrosinemia
por: Sarodaya, Neha, et al.
Publicado: (2020)

Case of hepatocellular carcinoma in a patient with hereditary tyrosinemia in the post-newborn screening era
por: Imseis, Essam M, et al.
Publicado: (2017)

Therapeutic Targeting of Fumaryl Acetoacetate Hydrolase in Hereditary Tyrosinemia Type I
por: Gil-Martínez, Jon, et al.
Publicado: (2021)

Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1
por: Li, Li, et al.
Publicado: (2017)

Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1)
por: Das, Anibh Martin
Publicado: (2017)

Phenotype, genotype, and outcome of 25 Palestinian patients with hereditary tyrosinemia type 1
por: Dweikat, Imad, et al.
Publicado: (2021)

Hereditary Tyrosinemia Compounded With Hyperinsulinemic Hypoglycemia: Challenging Diagnosis of a Rare Case
por: Nasir, Sharmeen, et al.
Publicado: (2020)

Hepatorenal tyrosinemia
por: KITAGAWA, Teruo
Publicado: (2012)

Colour variability of hair coat in successive unselected generation of standard mink
por: Maciejowski, J, et al.
Publicado: (1982)

Generation of immunodeficient pig with hereditary tyrosinemia type 1 and their preliminary application for humanized liver
por: Ren, Jilong, et al.
Publicado: (2022)

Tyrosinemia type III in an asymptomatic girl
por: Szymanska, Edyta, et al.
Publicado: (2015)

Heat Shock Response Associated with Hepatocarcinogenesis in a Murine Model of Hereditary Tyrosinemia Type I
por: Angileri, Francesca, et al.
Publicado: (2014)

Experience of a Single Center in NTBC Use in Management of Hereditary Tyrosinemia Type I in Libya
por: Alobaidy, Hanna, et al.
Publicado: (2015)

Wild mink (Neovison vison) as sentinels in environmental monitoring
por: Persson, Sara, et al.
Publicado: (2012)

Plantar keratoderma: a manifestation of tyrosinemia type II (Richner-Hanhart Syndrome)
por: Al-Ratrout, Jihad T., et al.
Publicado: (2005)

Exploring the therapeutic potential of modern and ancestral phenylalanine/tyrosine ammonia-lyases as supplementary treatment of hereditary tyrosinemia
por: Hendrikse, Natalie M., et al.
Publicado: (2020)

Diagnostic and Therapeutic Challenges of Hereditary Tyrosinemia Type 1 in Lebanon: A 12-Year Retrospective Review
por: Daou, Karim N., et al.
Publicado: (2021)

Novel Mutation of Tyrosinemia in a Child With Hypophosphatemic Rickets
por: Dogra, Surabhi, et al.
Publicado: (2022)

Efficient liver repopulation of transplanted hepatocyte prevents cirrhosis in a rat model of hereditary tyrosinemia type I
por: Zhang, Ludi, et al.
Publicado: (2016)

In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions
por: Nicolas, Clara T., et al.
Publicado: (2022)

mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model
por: Cacicedo, Maximiliano L., et al.
Publicado: (2022)

Hereditary Aspects of Colorectal Cancer: Mismatch Repair Genes Drive Lynch Syndrome
por: Hampel, Heather, et al.
Publicado: (2018)

Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype
por: Neuckermans, Jessie, et al.
Publicado: (2023)

Neurological Crises after Discontinuation of Nitisinone (NTBC) Treatment in Tyrosinemia
por: HONAR, Naser, et al.
Publicado: (2017)

Comment on Pancreatitis in Type 1 Tyrosinemia
por: Rahmoune, Hakim, et al.
Publicado: (2017)

Hereditary tyrosinemia type I–associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate
por: Macias, Iratxe, et al.
Publicado: (2019)

Identification of circulating microRNAs during the liver neoplastic process in a murine model of hereditary tyrosinemia type 1
por: Angileri, Francesca, et al.
Publicado: (2016)

The future of gene-targeted therapy for hereditary tyrosinemia type 1 as a lead indication among the inborn errors of metabolism
por: Thompson, Whitney S., et al.
Publicado: (2020)

A Case of Tyrosinemia Type III with Status Epilepticus and Mental Retardation
por: Najafi, Reza, et al.
Publicado: (2018)

TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW
por: Barroso, Fábio, et al.
Publicado: (2020)

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans
por: Oude Munnink, Bas B., et al.
Publicado: (2021)

Neonatal hyperinsulinism in transient and classical forms of tyrosinemia
por: Sethuram, Swathi, et al.
Publicado: (2021)

Treatment adherence in tyrosinemia type 1 patients
por: González-Lamuño, Domingo, et al.
Publicado: (2021)

A missense mutation (Q279R) in the Fumarylacetoacetate Hydrolase gene, responsible for hereditary tyrosinemia, acts as a splicing mutation
por: Dreumont, Natacha, et al.
Publicado: (2001)

Initial presentation, management and follow-up data of 33 treated patients with hereditary tyrosinemia type 1 in the absence of newborn screening
por: Hajji, Hela, et al.
Publicado: (2022)

Identification of Novel Mutations in FAH Gene and Prenatal Diagnosis of Tyrosinemia in Indian Family
por: Sheth, Jayesh J., et al.
Publicado: (2012)

Adenine base editing in an adult mouse model of tyrosinemia
por: Song, Chun-Qing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pcovhr5aapus2p8flqqtg12sfg